EDITORIAL COMMENT
The importance of being synchronous
on the prognostic value of ventricular conduction delay in heart failure*
Chistoph Stellbrink, MDFESC
,* and
Bernd Nowak, MD
* Department of Cardiology and Internal Medicine, Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany
Department of Department of Nuclear Medicine, Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany
* Reprint requests and correspondence: Dr. Christoph Stellbrink, Medizinische Klinik I, RWTH Aachen, Pauwelsstrasse 30, D-52057 Aachen, Germany.
cstellbrink{at}ukaachen.de
It has long been recognized that prolongation of the QRS complex in the surface electrocardiogram is an independent predictor of an adverse outcome in patients with heart failure (HF) (1,2). In most patients with dilated cardiomyopathy, QRS prolongation presents as a left bundle branch block (LBBB) (3,4). Not only is LBBB a marker of disease progression in cardiomyopathy but the ventricular dyssynchrony associated with ventricular conduction delay may have negative hemodynamic consequences: it can reduce contractility (5) and ejection fraction (6), shorten diastolic filling time (7), and cause functional mitral regurgitation (8). Thus, ventricular conduction disturbance in HF may lead to a vicious circle with further hemodynamic deterioration and left ventricular (LV) dilation. There is experimental evidence that asynchronous LV activation results in a reduced work in early-activated regions (i.e., the septum in LBBB) and increased work in late-activated regions (i.e., the LV free wall) (9) which causes asymmetric LV hypertrophy (10). This may be explained on the basis of regional disparities in the expression of calcium handling and stress proteins (11).
The prognostic implications of increased interventricular and intraventricular dyssynchrony in HF patients with prolonged QRS complex are yet unclear. In this issue of the Journal, Fauchier et al. (12) analyzed the prognostic importance of LV intraventricular versus interventricular dyssynchrony as analyzed by radionuclide scintigraphy in patients with nonischemic cardiomyopathy. The main finding was that increased LV intraventricular dyssynchrony was predictive of major cardiac events, as defined by cardiac death or worsening of HF leading to heart transplantation, but not interventricular dyssynchrony. However, the risk of a major cardiac event was only mildly elevated for patients with increased intraventricular dyssynchrony as indicated by a hazard ratio of only 1.021.
The evaluation of the pathophysiologic consequences of cardiac conduction disturbances, such as LBBB, is an interesting new application for cardiac nuclear imaging. Beyond functional assessment of interventricular and intraventricular dyssynchrony by Fourier phase analysis of equilibrium radionuclide angiography as performed by Fauchier et al. (12), nuclear imaging techniques have also been used to study the effects of LBBB on myocardial perfusion and metabolism. A reduction in septal glucose uptake with preserved myocardial blood flow (13) has been noted in LBBB caused by dilated cardiomyopathy, whereas there is ongoing discussion on the effects on oxidative metabolism (14,15). Cardiac resynchronization therapy (CRT), which aims to correct the hemodynamic disturbances caused by ventricular dyssynchrony in patients with moderate-to-advanced HF and LBBB, has been shown to have some positive impact on the metabolic effects of ventricular dyssynchrony. Preliminary data suggest improved myocardial oxygen consumption during low-dose dobutamine stress with biventricular (BV) pacing as determined by 11C-acetate positron emission tomography (16) and a restoration of a homogeneous myocardial glucose metabolism as shown by 18F-fluorodeoxyglucose positron emission tomography (17).
Acute hemodynamic (1820) and mid-term functional improvement (2123) as well as a reverse remodeling effect (2427) have been demonstrated with CRT. Cardiac resynchronization is usually achieved by atrial triggered BV pacing, but it is unclear whether BV pacing is necessary to achieve optimal ventricular resynchronization or whether it is sufficient to pace only the LV. Currently available evidence suggests that there is no clear advantage of BV over LV pacing, but most studies are limited by small sample sizes (22), nonrandomized study design (28), or no direct comparison of both approaches (29). The real question behind this debate is whether it is necessary to achieve interventricular synchronization or whether it is sufficient to correct LV intraventricular dyssynchrony. Parameters of interventricular dyssynchrony such as the interventricular mechanical delay derived from echocardiography are being used to identify patients suitable for CRT, based on the assumption that correction of interventricular dyssynchrony may be an adequate therapeutic target (30). The data from the study by Fauchier et al. (12) do not support this hypothesis because interventricular dyssynchrony did not prove to be of prognostic importance. In contrast, increased LV intraventricular dyssynchrony is not only relevant for prognosis but has also been shown to predict a positive response to CRT (31,32). If only the LV has to be resynchronized, one may speculate that LV pacing alone, with a critically timed atrioventricular delay allowing fusion with intrinsic conduction through the right bundle branch, is enough to achieve optimal hemodynamic support in HF patients with LBBB.
However, the argument that interventricular delay has some importance cannot be easily refuted. First, correction of interventricular dyssynchrony may still lead to hemodynamic improvement despite a lack of prognostic importance. A scintigraphic study by Kerwin et al. (33) using similar methodology as in the study presented in this issue of the Journal indicated that BV pacing mainly reduced interventricular but actually increased LV intraventricular dyssynchrony. However, these data were confounded by a heterogeneous patient population studied, including patients with right bundle branch block, ischemic heart disease, and only minor conduction delay. Moreover, LV lead position was not standardized, which is a critical determinant of therapeutic success in CRT. It is now accepted that a lateral or posterior LV lead position, i.e., in the area of the LV that is usually activated with the greatest delay in LBBB, provides optimal ventricular resynchronization and, thus, hemodynamic support (34).
Second, the positive hemodynamic impact of correcting LV intraventricular dyssynchrony by CRT may not necessarily translate into improvement in prognosis. Previous studies with positive inotropic drugs (3537) have taught us to be cautious with assumptions on prognosis in therapeutic interventions that acutely improve cardiac hemodynamics. However, there is good reason to be optimistic that the hemodynamic benefit achieved by CRT may not be paid for by increased mortality because CRT does not seem to increase myocardial oxygen demand as opposed to positive inotropic drugs (38).
Third, another aspect of the study by Fauchier et al. (12) deserves our attention: there may be a potential hazard of right ventricular (RV) desynchronization caused by CRT as RV intraventricular dyssynchrony was found to be predictive of an adverse outcome at least by univariate analysis; LV pacing alone especially may lead to substantial RV desynchronization. This may not only impair RV hemodynamic performance (39) and promote the occurrence of right-sided HF but may also potentially have a negative prognostic impact. This could be an advantage of BV over LV resynchronization because it does not appear to increase RV dyssynchrony substantially (33). However, in animal studies even BV pacing has been shown to impair RV hemodynamics acutely (40). Moreover, there are only very few long-term data with CRT and no data on RV function after long-term LV or BV pacing to the best of our knowledge.
Currently, there are no prospective data available on the influence of CRT on mortality in patients with HF. Thus, any discussion about the prognostic impact of interventricular versus intraventricular resynchronization remains speculative. Hopefully, the ongoing COMPANION study (41), which analyzes all-cause mortality as the primary study end point, and the CARE-HF (30) study, investigating the combined end point of all-cause mortality and unplanned cardiovascular hospitalizations, will answer the question of whether CRT has a positive impact on these significant clinical end points. However, both studies only apply BV pacing and, therefore, the question of whether correction of interventricular dyssynchrony is necessary will not be answered.
Caution needs to be taken when interpreting the data presented by Fauchier et al. (12) on the correlation of intraventricular and interventricular dyssynchrony to hemodynamic parameters. Intraventricular dyssynchrony in both ventricles appeared to correlate to echocardiographic measurements of LV function (end-diastolic and end-systolic diameter, ejection fraction) and to cardiac index, whereas only RV dyssynchrony correlated to functional parameters (New York Heart Association [NYHA] functional class, peak oxygen consumption) and RV ejection fraction. Even more surprising, interventricular delay showed an inverse correlation to NYHA functional class, i.e., less interventricular dyssynchrony was associated with functional impairment. It is likely that echocardiograms and radionuclide scans were not taken on the same day and the correlations were confounded by differences in volume status of the patients. No data on drug treatment are provided, which further limits the relevance of the observed correlations. In addition, the assessment of NYHA functional class may be too imprecise to allow for a meaningful correlation with the scintigraphic data. Nevertheless, the data should at least raise our attention to the potential importance of RV dyssynchrony in patients with HF, which has frequently been neglected in the discussion on CRT.
Clearly, more questions are raised than answers provided by the data from the Fauchier et al. (12) study. However, the study sheds some light on the importance of ventricular conduction disturbance in a relevant number of patients with dilated cardiomyopathy, and the authors should be credited for this effort. At present, we can only conclude that for patients suffering from systolic HF it is obviously of prognostic important that LV contraction is in synchrony. There is great hope that CRT may therefore improve prognosis in HF patients with ventricular conduction delay.
 |
Footnotes
|
|---|
* Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of the JACC or the American College of Cardiology. 
 |
References
|
|---|
- Aaronson KD, Schwartz S, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:26602667[Abstract/Free Full Text]
- Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143:398405[CrossRef][Medline]
- Grimm W, Glaveris C, Hoffmann J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study. Pacing Clin Electrophysiol. 1998;21:25512556[CrossRef][Medline]
- De Maria R, Gavazzi A, Recalcati F, Baroldi G, De Vita C, Camerini F. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am J Cardiol. 1993;72:580585[CrossRef][Medline]
- Xiao HB, Brecker SD, Gibson DG. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J. 1992;68:403407
- Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 1989;79:845853[Abstract/Free Full Text]
- Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J. 1991;66:443447[Abstract/Free Full Text]
- Erlebacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol. 2001;88:8386
- Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33:17351742[Abstract/Free Full Text]
- van Oosterhout MFM, Prinzen FW, Arts T, et al. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation. 1998;98:588595[Abstract/Free Full Text]
- Leclercq C, Faris O, Halperin H, et al. Regional disparity of calcium handling and stress protein expression in failing hearts with dyssynchronous contraction. (abstr)Circulation. 2001;104(Suppl S):S614
- Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP. Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with Fourier phase analysis of radionuclide angioscintigraphy. J Am Coll Cardiol. 2002;40:20222030[Abstract/Free Full Text]
- Zanco P, Desideri A, Mobilia G, et al. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med. 2000;41:973977[Abstract/Free Full Text]
- Zanco P, Chierichetti F, Fini A, Cargnel S, Ferlin G. Myocardial perfusion, glucose utilization and oxidative metabolism in a patient with left bundle branch block, prior myocardial infarction and diabetes. J Nucl Med. 1998;39:261263[Abstract/Free Full Text]
- Baller D, Holzinger J, Vogt J, et al. Asynchronous contraction in dilated cardiomyopathy with left bundle branch block is associated with regional dysbalance of oxidative metabolism measured by C-11-acetate PET. (abstr)Circulation. 2001;104(Suppl):S2927
- Braunschweig F, Sorensen J, Rydén L, Linde C. Biventricular pacing improves myocardial oxygen consumption during stress: a study using carbon-11 acetate positron emission tomography. (abstr)Eur Heart J. 2001;22:442[Free Full Text]
- Nowak B, Stellbrink C, Sinha AM, et al. Cardiac resynchronization therapy by biventricular pacing in dilative cardiomyopathy and left bundle branch block: effects on myocardial perfusion and glucose metabolism. (abstr)J Nucl Med. 2002;43(Suppl):52P
- Auricchio A, Stellbrink C, Block M, et al. The effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation. 1999;99:29933001[Abstract/Free Full Text]
- Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 1999;99:15671573[Abstract/Free Full Text]
- Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation. 1997;96:32733277[Abstract/Free Full Text]
- Multisite Stimulation in Cardiomyopathies (MUSTIC) Study InvestigatorsCazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventeicular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873880[Abstract/Free Full Text]
- Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:18451853[Abstract/Free Full Text]
- Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:20262033[Abstract/Free Full Text]
- Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronisation therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbance. J Am Coll Cardiol. 2001;38:19571965[Abstract/Free Full Text]
- Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation. 2002;105:13041310[Abstract/Free Full Text]
- Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Doppler myocardial imaging to evaluate the effctiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol. 2002;39:489499[Abstract/Free Full Text]
- Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105:438445[Abstract/Free Full Text]
- Touiza A, Etienne Y, Gilard M, Fatemi M, Mansourati J, Blanc JJ. Long-term left ventricular pacing: assessment and comparison with biventricular pacing in patients with severe congestive heart failure. J Am Cardiol. 2001;38:19661970
- Stellbrink C, Auricchio A, Butter C, et al. Pacing therapies in congestive heart failure II study. Am J Cardiol. 2000;86(Suppl 1):K138143
- Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail. 2001;3:481489[CrossRef][Medline]
- Breithardt OA, Stellbrink C, Kramer AP, et al. Echocardiographic quantification of left ventricular asynchrony predicts an acute benefit of cardiac resynchronization therapy. J Am Coll Cardiol. 2002;40:536545[Abstract/Free Full Text]
- Nelson GS, Curry CW, Wyman BT, et al. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation. 2000;101:27032709[Abstract/Free Full Text]
- Kerwin WF, Botvinick EH, OConnell W, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol. 2000;35:12211227[Abstract/Free Full Text]
- Butter C, Auricchio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation. 2001;104:30263029[Abstract/Free Full Text]
- The PROMISE Study Research GroupPacker M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:14681475[Abstract]
- Vesnarinone Trial InvestigatorsCohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med. 1998;339:18101816[Abstract/Free Full Text]
- Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) InvestigatorsHampton JR, van Veldhuisen DJ, Kleber FX, et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet. 1997;349:971977[CrossRef][Medline]
- Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:30533059[Abstract/Free Full Text]
- Auricchio A, Ding J, Yu Y, et al. Comparison between the effect of pacing on the RV and LV systolic function of heart failure patients. (abstr)Pacing Clin Electrophysiol. 1999;22:831[CrossRef][Medline]
- Verbeek XAAM, Vernooy K, Dumitrescu G, Peschar M, Van der Nagel T, Prinzen FW. Relation between interventricular asynchrony and opposite changes in left and right ventricular function during left bundle branch block and resynchronization. (abstr)Circulation. 2001;104(Suppl):S1341
- COMPANION Steering Committee and COMPANION Clinical InvestigatorsBristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. J Card Fail. 2000;6:276285[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
M. O. Sweeney, A. S. Hellkamp, K. L. Lee, G. A. Lamas, and for the Mode Selection Trial (MOST) Investigators
Association of Prolonged QRS Duration With Death in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
Circulation,
May 17, 2005;
111(19):
2418 - 2423.
[Abstract]
[Full Text]
[PDF]
|
 |
|